Victor Stone M.D. (石井 喜英)

Victor Stone M.D. (石井 喜英) Email and Phone Number

Head of Cell Therapies | Japan, Alloy Therapeutics @ Alloy Therapeutics, Inc.
Cambridge, MA, US
Victor Stone M.D. (石井 喜英)'s Location
Cambridge, Massachusetts, United States, United States
Victor Stone M.D. (石井 喜英)'s Contact Details

Victor Stone M.D. (石井 喜英) work email

Victor Stone M.D. (石井 喜英) personal email

n/a
About Victor Stone M.D. (石井 喜英)

Victor Stone M.D. (石井 喜英) is a Head of Cell Therapies | Japan, Alloy Therapeutics at Alloy Therapeutics, Inc.. He possess expertise in financial modeling, strategic planning, strategy, business development, business strategy and 3 more skills. Colleagues describe him as "Mr. Stone and I have worked together since 2012 on the Japan International Immersion program with Harvard Business School. Over the course of these two years, he has shown tremendous attention, care and diligence in helping to provide an academically robust and culturally engaging experience for more than sixty second year MBA students. During our travels together throughout Japan, Mr. Stone’s research expertise and language skills proved critical in helping to facilitate meaningful and memorable engagements with top Japanese firms, entrepreneurs and thought leaders. In many ways, it is the support of business leaders like Mr. Stone that has made the International Immersion to Japan one of the School’s most popular course offerings, and one in which many MBA students recall as a truly formative part of their Harvard experience."

Victor Stone M.D. (石井 喜英)'s Current Company Details
Alloy Therapeutics, Inc.

Alloy Therapeutics, Inc.

View
Head of Cell Therapies | Japan, Alloy Therapeutics
Cambridge, MA, US
Website:
alloytx.com
Employees:
134
Victor Stone M.D. (石井 喜英) Work Experience Details
  • Alloy Therapeutics, Inc.
    Head Of Cell Therapies | Japan, Alloy Therapeutics
    Alloy Therapeutics, Inc.
    Cambridge, Ma, Us
  • Alloy Therapeutics, Inc.
    President Of 82Vs Venture Studios And Head Of Cell Therapies
    Alloy Therapeutics, Inc. Apr 2023 - Present
    Boston, Massachusetts, Us
    Alloy democratizes access to pre-competitive drug discovery technologies and services across six biologic modalities, and I am very excited to be taking a foundational role in building out the discovery services organization for cell therapy. The company already has an incredible footprint in antibodies and TCRs that I'm thrilled to expand on to empower the drug discovery community in their cell therapy endeavors. Company creation is also an exciting part of Alloy's business through 82VS, and I'm excited to partner with the team there around new companies to advance cell-therapy-based assets. We are still early in these efforts but please reach out if you are interested in exploring ways to collaborate and #makemedicinetogether.
  • 82Vs
    President Of 82Vs Venture Studios And General Partner Of 82Vs Fund
    82Vs Apr 2023 - Present
    Boston, Ma, Us
  • Shonan Health Innovation Park
    Consortia Director
    Shonan Health Innovation Park Oct 2020 - Present
    藤沢市, 神奈川県, Jp
    Japan VC Consortia is a consortia of over 20 Japanese biopharma (Pharma BD/CVC and Institutional VC) hosted by Shonan Health Innovation Park dedicated to actionable initiatives to advance the Japanese biotech ecosystem
  • Typewriter Therapeutics, Inc.
    Co-Founder
    Typewriter Therapeutics, Inc. Aug 2021 - Present
    Cambridge, Massachusetts, Us
  • Axcelead Drug Discovery Partners, Inc.
    Non Executive Director
    Axcelead Drug Discovery Partners, Inc. Apr 2019 - Present
    藤沢市, 神奈川県, Jp
    Largest small molecule platform in Japan, now a full-service pre-clinical CRO serving Japanese Biopharma clients. Spin out of R&D capabilities of Takeda Shonan Research Center including 240 high performing researchers
  • Takeda
    Senior Investment Director And Partner
    Takeda Jan 2020 - Mar 2023
    Tokyo, Jp
    Investments with focus in cell and gene therapies and new chemical space. Board Directorships summarized below. Board Observer roles include: Artisan Development Labs (Cas12a), Be BioPharma (Engineered B-Cell), Bridgene (PPI SMOL), RedPin Tx (AAV CNS), X-forest Tx (RNAi). Promoted to role in October 2021.
  • Code Biotherapeutics
    Non Executive Director
    Code Biotherapeutics Apr 2021 - Feb 2023
    Hatfield, Pennsylvania, Us
    Non-viral gene delivery platform based on 3-DNA scaffold technology. Versatile platform enabling base construct of 18 points for engagers and gene cargo. Unprecedented signal-noise ratio with tissue specific targeting.
  • Syngensys Limited
    Non Executive Director
    Syngensys Limited Jan 2022 - Jan 2023
    Sheffield, Gb
    Synthetic Promoter developer enabling tissue specific expression in gene therapy and optimization of biologics manufacturing. Spinout from University of Sheffield, David C James and Adam Brown labs
  • Enzyre B.V.
    Member Of The Supervisory Board
    Enzyre B.V. Apr 2021 - Jan 2023
    Nijmegen, Gelderland, Nl
    Mobile Diagnostics enabling point of care measurement of hematology biomarkers including Factor VIII, Von Willebrand Factor and Thrombin
  • Adaptate Biotherapeutics
    Non Executive Director
    Adaptate Biotherapeutics Sep 2021 - Apr 2022
    London, Gb
    Spinout from GammaDelta Therapeutics and supported by Abingworth and Takeda. Antibody approach to harness innate immune potential of gdT-cells for cancer immuno-therapy. Acquired by Takeda in April 2022
  • Artham Therapeutics (Subsidiary Of Kaken Pharmaceutical Co Ltd)
    Non Executive Director
    Artham Therapeutics (Subsidiary Of Kaken Pharmaceutical Co Ltd) Jun 2021 - Dec 2021
    Clinical stage biotech prosecuting rare disease with repositioned oncology therapies. Two programs now in Phase II studies: Bullous Pemphigoid and Slow Flow Venous Malformation. Acquired by Kaken Pharma for undisclosed amount in December 2021
  • Shattuck Labs
    Non Executive Director
    Shattuck Labs Apr 2020 - Oct 2020
    Austin, Texas, Us
    Clinical stage biotech developing Agonist Redirected Checkpoint (ARC) molecules, a novel form of bispecific-multivalent engagers. IPO in October 2021
  • Whiz Partners, Inc.
    Investment Director
    Whiz Partners, Inc. Feb 2014 - Jan 2020
    Alternative assets management firm with Private Equity and Hedgefund investing. PE elements with heavy focus on growing trade flow of Japanese technologies and robust demand from Chinese and ASEAN markets. Other elements include health and lifesciences business development and Global Macro investing. Flagship fund ranked among top small-cap PE funds in 2011 vintage.
  • Ignite, Inc.
    Chief Executive Officer
    Ignite, Inc. Nov 2010 - Jan 2020
    Start-up Display technologies firm with first in class technology in MEMS Semiconductor, Optics, and Video circuit algorithms. Operating elements in Silicon Valley, Shanghai, and Japan. Over 75 USPTO granted. Track record of multi-year collaborations with Auto, Electronics, and Telecom conglomerates. Close association with US sister company Iron City Micro Display, Inc.
  • United States Marine Corps
    Officer In Charge, Ii-Marine Air Wing Rotary Wing Medical
    United States Marine Corps Mar 2009 - Apr 2010
    Washington, Dc, Us
    Officer in Charge of all Marine Helicopter Medical Capabilities for the Atlantic Fleet. Trained and deployed forces to area of operations spanning Atlantic, Mediterranean, Africa, and Middle East. Strategic shift from Iraq to Afghanistan; Humanitarian operations in Haiti. Medical director of 18 physician, 67 person clinic providing outpatient care in Jacksonville, NC area.
  • United States Marine Corps
    Squadron Flight Surgeon
    United States Marine Corps May 2006 - Mar 2009
    Washington, Dc, Us
    Hybrid role as Helicopter Aircrewman and Physician in support of Marine operations with multiple combat deployments to Afghanistan, Iraq, and Somalia. Humanitarian service in Bangladesh. Presidential escort in Israel.

Victor Stone M.D. (石井 喜英) Skills

Financial Modeling Strategic Planning Strategy Business Development Business Strategy Cross Functional Team Leadership Valuation Due Diligence

Victor Stone M.D. (石井 喜英) Education Details

  • Harvard Business School
    Harvard Business School
    Mba
  • Thomas Jefferson University
    Thomas Jefferson University
    Medicine
  • Columbia College, Columbia University
    Columbia College, Columbia University
    Biology
  • Phillips Exeter Academy
    Phillips Exeter Academy

Frequently Asked Questions about Victor Stone M.D. (石井 喜英)

What company does Victor Stone M.D. (石井 喜英) work for?

Victor Stone M.D. (石井 喜英) works for Alloy Therapeutics, Inc.

What is Victor Stone M.D. (石井 喜英)'s role at the current company?

Victor Stone M.D. (石井 喜英)'s current role is Head of Cell Therapies | Japan, Alloy Therapeutics.

What is Victor Stone M.D. (石井 喜英)'s email address?

Victor Stone M.D. (石井 喜英)'s email address is vs****@****hbs.edu

What schools did Victor Stone M.D. (石井 喜英) attend?

Victor Stone M.D. (石井 喜英) attended Harvard Business School, Thomas Jefferson University, Columbia College, Columbia University, Phillips Exeter Academy.

What skills is Victor Stone M.D. (石井 喜英) known for?

Victor Stone M.D. (石井 喜英) has skills like Financial Modeling, Strategic Planning, Strategy, Business Development, Business Strategy, Cross Functional Team Leadership, Valuation, Due Diligence.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.